Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-629-2 | CAS number: 17647-86-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
Ames assay
Key
In a reverse mutation assay in bacteria, strains of Salmonella
typhimurium ( TA 1535, TA 100, TA 1537, TA 98) and Escherichia coli (
WP2 uvrA) were exposed to the test substance at concentrations of 0; 33;
100; 333; 1000; 2650 and 5300 μg/plate (BASF SE, 2015). A standard plate
test (SPT) and preincubation test (PIT) both with and without metabolic
activation (liver S9 mix from induced rats) were conducted.
No precipitation of the test substance was found with and without S9
mix. A bacteriotoxic effect was occasionally observed in the
preincubation test at a concentration of 5300 μg/plate. According to the
results of the present study, the test substance did not lead to a
relevant increase in the number of revertant colonies either without S9
mix or after adding a metabolizing system in two experiments carried out
independently of each other (standard plate test and preincubation
assay). Besides, the results of the negative as well as the positive
controls performed in parallel corroborated the validity of this study,
since the values fulfilled the acceptance criteria of this study. In
this study with and without S9 mix, the number of revertant colonies in
the negative controls was within the range of the historical negative
control data for each tester strain. In addition, the positive control
substances both with and without S9 mix induced a significant increase
in the number of revertant colonies within, marginally below or above
the range of the historical positive control data.
Thus, under the experimental conditions of this study, the test
substance is not mutagenic in the Salmonella typhimurium/Escherichia
coli reverse mutation assay in the absence and the presence of metabolic
activation.
Supporting
Two publications further support the key study on bacterial reverse
mutation. Hoorn et al. (1989) used the read across substance N,
N-dimethylglycine hydrochloride (CAS# 2491-06-7) and tested the S.
typhimurium strains TA100 and TA1535 with and without metabolic
activation. Colman et al. tested the S. typhimurium strains TA1535,
TA1537, TA1538, TA98 and TA100 with the above mentioned read across
substance with and without metabolic activation. No mutagenic properties
were observed with or without S9 mix in both publications.
HPRT assay
The test substance was assessed for its potential to induce gene
mutations at the hypoxanthine-guanine phosphoribosyl transferase (HPRT)
locus in Chinese hamster ovary (CHO) cells in vitro according to OECD
guideline 476 and EU method B.17. Two independent experiments were
carried out, both with and without the addition of liver S9 mix from
phenobarbital- and β-naphthoflavone induced rats (exogenous metabolic
activation). According to an initial range-finding cytotoxicity test for
the determination of the experimental doses, the following
concentrations were tested.
1st Experiment
without S9 mix:
0; 100.0; 200.0; 400.0; 800.0; 1600.0 μg/mL
[0; 200.0; 400.0; 800.0; 1600.0 μg/mL were evaluated for gene mutations]
with S9 mix:
0; 100.0; 200.0; 400.0; 800.0; 1600.0 μg/mL
[0; 200.0; 400.0; 800.0; 1600.0 μg/mL were evaluated for gene mutations]
2nd Experiment
without S9 mix:
0; 87.5; 175.0; 350.0; 700.0; 1600.0 μg/mL
[0; 175.0; 350.0; 700.0; 1600.0 μg/mL were evaluated for gene mutations]
with S9 mix:
0; 87.5; 175.0; 350.0; 700.0; 1600.0 μg/mL
[0; 175.0; 350.0; 700.0; 1600.0 μg/mL were evaluated for gene mutations]
Following attachment of the cells for 20 -
24 hours, cells were treated with the test substance for 4 hours in the
absence and presence of metabolic activation. Subsequently, cells were
cultured for 6 - 8 days and then selected in 6-thioguanine-containing
medium for another week. Finally, the colonies of each test group were
fixed with methanol, stained with Giemsa and counted. The vehicle
controls gave mutant frequencies within the range expected for the CHO
cell line. Both positive control substances, ethyl methanesulfonate
(EMS) and 7,12-dimethylbenz[a]anthracene (DMBA), led to the expected
increase in the frequencies of forward mutations. In this study in the
absence and the presence of metabolic activation no cytotoxicity was
observed up to the highest required concentration evaluated for gene
mutations. Based on the results of the present study, the test substance
did not cause any relevant increase in the mutant frequencies either
without S9 mix or after the addition of a metabolizing system in two
experiments performed independently of each other.
Thus, under the experimental conditions of this study, the test
substance is not mutagenic in the HPRT locus assay under in vitro
conditions in CHO cells in the absence and the presence of metabolic
activation.
Micronucleus assay
The test substance was assessed for its potential to induce
micronuclei in V79 cells in vitro (clastogenic or aneugenic activity)
according to OECD guideline 487 and EU method B.49. Two independent
experiments were carried out, both with and without the addition of
liver S9 mix from induced rats (exogenous metabolic activation). Based
on the observations and the toxicity data of a previously performed
pretest for a HPRT study (BASF project No. 50M0456/01M022) the following
concentrations were tested.
1st Experiment
4 hours exposure, 24 hours harvest time, without S9 mix:
0; 50.0; 100.0; 200.0; 400.0; 800.0; 1600.0 μg/mL
[0; 400.0; 800.0; 1600.0 μg/mL were evaluated]
4 hours exposure, 24 hours harvest time, with S9 mix:
0; 50.0; 100.0; 200.0; 400.0; 800.0; 1600.0 μg/mL
[0; 400.0; 800.0; 1600.0 μg/mL were evaluated]
2nd Experiment
24 hours exposure, 24 hours harvest time, without S9 mix:
0; 200.0; 400.0; 800.0; 1600.0 μg/mL
[0; 400.0; 800.0; 1600.0 μg/mL were evaluated]
4 hours exposure, 44 hours harvest time, with S9 mix:
0; 200.0; 400.0; 800.0; 1600.0 μg/mL
[0; 400.0; 800.0; 1600.0 μg/mL were evaluated]
A sample of at least 1000 cells for each culture was analyzed for micronuclei, i.e. 2000 cells for each test group. The negative controls gave frequencies of micronucleated cells within our historical negative control data range for V79 cells. Both positive control substances, ethyl methanesulfonate (EMS) and cyclophosphamide (CPP), led to the expected increase in the number of cells containing micronuclei. In this study, no cytotoxicity indicated by reduced cell count (indicated by relative population doubling) or proliferation index (CBPI) was observed up to the highest applied test substance concentration. On the basis of the results of the present study, the test substance did not cause any biologically relevant increase in the number of cells containing micronuclei either without S9 mix or after adding a metabolizing system. Thus, under the experimental conditions described, potassium N,N-dimethylglycinate is considered not to have a chromosome-damaging (clastogenic) effect nor to induce numerical chromosomal aberrations (aneugenic activity) under in vitro conditions in V79 cells in the absence and the presence of metabolic activation.
Justification for selection of genetic toxicity endpoint
GLP and guideline compliant study reports are available to assess the mutagenic acitivity of the test substance.
Short description of key information:
In a reverse gene mutation assay in bacteria (Ames Test), no mutagenicity was observed with or without metabolic activation. (BASF SE, 2015). No mutant colonies were detected in the in vitro mammalian cell gene mutation test examining the HPRT locus of Chinese hamster ovary cells (BASF SE, 2015). The test substancde did not show any potential to induce micronuclei under in vitro conditions in a micronucleus assay using the cytokinesis block method (BASF SE, 2016).
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
The available experimental test data are reliable and suitable for classification purposes under Regulation 1272/2008. As a result the substance does not need to be classified and labelled for genetic toxicity under Regulation (EC) No 1272/2008, as amended for the seventh time in Regulation (EU) No 2015/1221.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.